Clinical Trials Browser

OTHER × Esophageal Squamous Cell Carcinoma × penpulimab × Clear all

NCT05265962 2022-03-04

Decitabine Plus Penpulimab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma